<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Tardive dystonia</dc:title>
  <dc:creator>VAN HARTEN, P. N</dc:creator>
  <dc:creator>KAHN, R. S</dc:creator>
  <dc:relation>Schizophrenia bulletin -- Schizophr. bull, CODEN SCZBB3, ISSN 0586-7614, Vol. 25 (4) , pp. 741-748</dc:relation>
  <dc:date>1999</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Oxford University Press</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>3 p</dc:format>
  <dc:subject xml:lang="fr">Enzyme</dc:subject>
  <dc:subject xml:lang="fr">Extrapyramidal syndrome</dc:subject>
  <dc:subject xml:lang="fr">Hydrolases</dc:subject>
  <dc:subject xml:lang="fr">Metalloendopeptidases</dc:subject>
  <dc:subject xml:lang="fr">Mouvement involontaire</dc:subject>
  <dc:subject xml:lang="fr">Muscle strié pathologie</dc:subject>
  <dc:subject xml:lang="fr">Peptidases</dc:subject>
  <dc:subject xml:lang="fr">Système nerveux pathologie</dc:subject>
  <dc:subject xml:lang="fr">Trouble neurologique</dc:subject>
  <dc:subject xml:lang="fr">Antagoniste</dc:subject>
  <dc:subject xml:lang="fr">Article synthèse</dc:subject>
  <dc:subject xml:lang="fr">Atypique</dc:subject>
  <dc:subject xml:lang="fr">Bontoxilysin</dc:subject>
  <dc:subject xml:lang="fr">Complication</dc:subject>
  <dc:subject xml:lang="fr">Diagnostic différentiel</dc:subject>
  <dc:subject xml:lang="fr">Dyskinésie</dc:subject>
  <dc:subject xml:lang="fr">Dystonie</dc:subject>
  <dc:subject xml:lang="fr">Epidémiologie</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">International</dc:subject>
  <dc:subject xml:lang="fr">Long terme</dc:subject>
  <dc:subject xml:lang="fr">Neuroleptique</dc:subject>
  <dc:subject xml:lang="fr">Phénoménologie</dc:subject>
  <dc:subject xml:lang="fr">Prévalence</dc:subject>
  <dc:subject xml:lang="fr">Psychotrope</dc:subject>
  <dc:subject xml:lang="fr">Récepteur dopaminergique</dc:subject>
  <dc:subject xml:lang="fr">Santé mentale</dc:subject>
  <dc:subject xml:lang="fr">Santé publique</dc:subject>
  <dc:subject xml:lang="fr">Tardif</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Utilisation</dc:subject>
  <dc:subject xml:lang="fr">Changement médicament</dc:subject>
  <dc:subject xml:lang="en">Enzyme</dc:subject>
  <dc:subject xml:lang="en">Extrapyramidal syndrome</dc:subject>
  <dc:subject xml:lang="en">Hydrolases</dc:subject>
  <dc:subject xml:lang="en">Metalloendopeptidases</dc:subject>
  <dc:subject xml:lang="en">Involuntary movement</dc:subject>
  <dc:subject xml:lang="en">Striated muscle disease</dc:subject>
  <dc:subject xml:lang="en">Peptidases</dc:subject>
  <dc:subject xml:lang="en">Nervous system diseases</dc:subject>
  <dc:subject xml:lang="en">Neurological disorder</dc:subject>
  <dc:subject xml:lang="en">Antagonist</dc:subject>
  <dc:subject xml:lang="en">Review</dc:subject>
  <dc:subject xml:lang="en">Atypical</dc:subject>
  <dc:subject xml:lang="en">Bontoxilysin</dc:subject>
  <dc:subject xml:lang="en">Complication</dc:subject>
  <dc:subject xml:lang="en">Differential diagnostic</dc:subject>
  <dc:subject xml:lang="en">Dyskinesia</dc:subject>
  <dc:subject xml:lang="en">Dystonia</dc:subject>
  <dc:subject xml:lang="en">Epidemiology</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">International</dc:subject>
  <dc:subject xml:lang="en">Long term</dc:subject>
  <dc:subject xml:lang="en">Neuroleptic</dc:subject>
  <dc:subject xml:lang="en">Phenomenology</dc:subject>
  <dc:subject xml:lang="en">Prevalence</dc:subject>
  <dc:subject xml:lang="en">Psychotropic</dc:subject>
  <dc:subject xml:lang="en">Dopamine receptor</dc:subject>
  <dc:subject xml:lang="en">Mental health</dc:subject>
  <dc:subject xml:lang="en">Public health</dc:subject>
  <dc:subject xml:lang="en">Late</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Use</dc:subject>
  <dc:subject xml:lang="en">Drug switching</dc:subject>
  <dc:subject xml:lang="es">Enzima</dc:subject>
  <dc:subject xml:lang="es">Extrapiramidal síndrome</dc:subject>
  <dc:subject xml:lang="es">Hydrolases</dc:subject>
  <dc:subject xml:lang="es">Metalloendopeptidases</dc:subject>
  <dc:subject xml:lang="es">Movimiento involuntario</dc:subject>
  <dc:subject xml:lang="es">Músculo estriado patología</dc:subject>
  <dc:subject xml:lang="es">Peptidases</dc:subject>
  <dc:subject xml:lang="es">Sistema nervioso patología</dc:subject>
  <dc:subject xml:lang="es">Trastorno neurológico</dc:subject>
  <dc:subject xml:lang="es">Antagonista</dc:subject>
  <dc:subject xml:lang="es">Artículo síntesis</dc:subject>
  <dc:subject xml:lang="es">Atípico</dc:subject>
  <dc:subject xml:lang="es">Bontoxilysin</dc:subject>
  <dc:subject xml:lang="es">Complicación</dc:subject>
  <dc:subject xml:lang="es">Diagnóstico diferencial</dc:subject>
  <dc:subject xml:lang="es">Disquinesia</dc:subject>
  <dc:subject xml:lang="es">Distonía</dc:subject>
  <dc:subject xml:lang="es">Epidemiología</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Internacional</dc:subject>
  <dc:subject xml:lang="es">Largo plazo</dc:subject>
  <dc:subject xml:lang="es">Neuroléptico</dc:subject>
  <dc:subject xml:lang="es">Fenomenología</dc:subject>
  <dc:subject xml:lang="es">Prevalencia</dc:subject>
  <dc:subject xml:lang="es">Psicotropo</dc:subject>
  <dc:subject xml:lang="es">Receptor dopaminérgico</dc:subject>
  <dc:subject xml:lang="es">Salud mental</dc:subject>
  <dc:subject xml:lang="es">Salud pública</dc:subject>
  <dc:subject xml:lang="es">Tardío</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject xml:lang="es">Utilización</dc:subject>
  <dc:subject>002B02B03: Psycholeptiques: tranquillisant, neuroleptique. / Psycholeptics: tranquillizer, neuroleptic.</dc:subject>
  <dc:subject>770-: Psychologie. Psychanalyse. Psychiatrie / Psychology. Psychoanalysis. Psychiatry</dc:subject>
  <dc:subject>770-E: Psychopharmacologie / Psychopharmacology</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 1218913</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>